Table 5 Treatment courses and outcomes of children with PIV infections
Total | PIV1 | PIV2 | PIV3 | p value | ||
|---|---|---|---|---|---|---|
n = 78 | n = 32 | n = 5 | n = 41 | |||
Hospitalization days | 7 (5,8) | 6 (5,8) | 7 (4.5, 8.5) | 7 (6,9) | 0.535 | |
ICU admission | 6 (7.7%) | 1 (3.1%) | 0 | 5 (12.2%) | 0.223 | |
Febrile days after admission | 1 (0,2.5) | 1 (0, 2) | 4 (1.5, 6.5) | 1 (0, 2) | 0.226 | |
Antibiotics use | 57 (73.1%) | 26 (81.2%) | 3 (60.0%) | 28 (68.3%) | 0.332 | |
Methylprednisolone use | 13 (16.7%) | 2 (6.2%) | 1 (20.0%) | 10 (24.4%) | 0.090 | |
Mechanical ventilation | 2 (2.6%) | 1 (3.1%) | 0 | 1 (2.4%) | 0.864 | |